The Journal of infectious diseases
Limited Antimycobacterial Efficacy of Epitope Peptide Administration Despite Enhanced Antigen-Specific CD4 T-Cell Activation.
The Clinical-Translational Physician-Scientist: Translating Bedside to Bench.
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes.
Macrophage Activation Marker Soluble CD163 is a Dynamic Marker of Liver Fibrogenesis in HIV/HCV Coinfection.
Increased Systemic Inflammation and Gut Permeability Among Women with Treated HIV Infection in Rural Uganda.
Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial.
Anatomy of a Hotspot: Chain and Seroepidemiology of Ebola Virus Transmission, Sukudu, Sierra Leone, 2015-16.
Can Biomarkers Advance HIV Research and Care in the Antiretroviral Therapy Era?
All About the Albumin? Prognostic Capacity of Serum Albumin in Patients With Treated HIV Infection.
Changes in inflammation but not in T cell activation precede non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy.
